The outcome of infected total knee arthroplasty: culture-positive versus culture-negative

Arch Orthop Trauma Surg. 2015 Oct;135(10):1459-67. doi: 10.1007/s00402-015-2286-7. Epub 2015 Jul 19.

Abstract

Purpose: We studied the outcome in culture-positive and culture-negative infected total knee arthroplasty (TKA).

Methods: We retrospectively reviewed 140 patients with culture-positive and 102 patients with culture-negative infected TKAs. We determined the infection control rate and clinical outcome after repeated debridement, and repeated 2-stage TKA in the culture-positive and culture-negative groups. The mean follow-up was 9.3 years (range 5-14 years) in the culture-positive group and 10.6 years (5-22) in the culture-negative group.

Results: The overall infection control rate was 56 % in both groups after the first treatment. The overall infection control rate was 90 % in the culture-positive group and 95 % in the culture-negative group. A functional knee was obtained in 90 % in the culture-positive group and 95 % in the culture-negative group.

Conclusions: The data suggest that treatment according to the types of infection in both culture-positive and culture-negative groups after TKA controlled infection and maintained functional TKA with a firm level of fixation for most patients. Repeated debridement and repeated two-stage exchange TKA further improved infection control rates after the initial treatment and increased the likelihood of maintaining a functional TKA.

Keywords: Culture-negative; Culture-positive; Infection control rate; TKA.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use*
  • Arthroplasty, Replacement, Knee / adverse effects*
  • Bacteria / isolation & purification*
  • Debridement / methods*
  • Female
  • Humans
  • Knee Prosthesis / adverse effects*
  • Male
  • Middle Aged
  • Prosthesis-Related Infections / microbiology
  • Prosthesis-Related Infections / therapy*
  • Reoperation
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents